Back to Atlas
CTransientStandard research/education caution
CMP-0271
Investigational; prohibited in sport
Andarine / S-4 / GTx-007
Ergogenic / SARM
Lean-mass and strength positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- SARM
- Primary mechanism
- Selective androgen receptor agonism
- Primary market use
- Performance misuse
Pharmacology
- Molecular weight (Da)
- 441.36
- Oral bioavailability
- Oral; ~38-91% in animal data
- Half-life
- ~3.8-4 h
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical/early clinical
- Clinical status
- Investigational; prohibited in sport
- Value-for-money score
- 2 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Vision side-effect reputation and short half-life reduce practical value